首页> 外文期刊>Systematic Reviews >Appraisal of clinical practice guidelines for management of paediatric type 2 diabetes mellitus using the AGREE II instrument: a systematic review protocol
【24h】

Appraisal of clinical practice guidelines for management of paediatric type 2 diabetes mellitus using the AGREE II instrument: a systematic review protocol

机译:评估使用AGREE II仪器管理小儿2型糖尿病的临床实践指南:系统评价方案

获取原文
           

摘要

Background The prevalence of type 2 diabetes mellitus (T2DM) in children and adolescents is increasing. This has spurred the development and publication of clinical practice guidelines (CPGs) for the management of paediatric T2DM. Given the long-term complications of T2DM, optimal management is important to prevent or delay these complications. However, the quality of published CPGs has not yet been empirically evaluated. Our objective is to systematically appraise all published CPGs for the management of T2DM in children and adolescents. Methods We will identify all published CPGs that address T2DM in children and adolescents through MEDLINE, Embase, CINAHL, Trip, and the National Guideline Clearinghouse and will screen diabetes and paediatric societies and associations’ websites. Search records will be screened in duplicate for inclusion. Grey literature will be covered by systematically searching publications of all relevant diabetes societies and associations and other health organizations for CPGs that meet our inclusion criteria. CPGs deemed eligible for inclusion will be retrieved. Quality assessment will be conducted using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool by a team of four appraisers. Scaled scores of the AGREE II will be used to gauge the overall quality of CPGs. Discussion The results of this review will be disseminated through presentations at local, national, and international conferences and publication in a peer-reviewed journal. The results of this review can help improve the reporting of future guidelines, inform decisions of policy-makers to endorse CPGs, and affect the choice of guideline use in clinical practice. Systematic review registration PROSPERO CRD42016034187
机译:背景技术2型糖尿病(T2DM)在儿童和青少年中的患病率正在上升。这刺激了儿科T2DM管理的临床实践指南(CPG)的开发和发布。考虑到T2DM的长期并发症,最佳管理对于预防或延迟这些并发症很重要。但是,尚未通过经验评估已发布的CPG的质量。我们的目标是系统评估所有发布的CPG,以管理儿童和青少年的T2DM。方法我们将通过MEDLINE,Embase,CINAHL,Trip和国家指南交换所确定所有已发布的解决儿童和青少年T2DM的CPG,并将筛查糖尿病和小儿社会及协会的网站。搜索记录将一式两份进行筛选以包括在内。灰色文献将覆盖所有相关糖尿病协会和协会以及其他卫生组织的出版物,以搜索符合我们纳入标准的CPG。被认为符合资格的CPG将被检索。由四个评估人员组成的小组将使用《研究和评估指南评估II》(AGREE II)工具进行质量评估。 AGREE II的评分标准将用于衡量CPG的整体质量。讨论审查的结果将通过在地方,国家和国际会议上的演讲进行传播,并在同行评审的期刊上发表。审查的结果可以帮助改善对未来指南的报告,为决策者提供支持CPG的决策依据,并影响在临床实践中使用指南的选择。系统审核注册PROSPERO CRD42016034187

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号